Policy & Partnerships ABPI actively collaborates with Government and the NHS to accelerate access to new medicines. This suggests sales opportunities around policy advisory services, regulatory intelligence, and compliance support designed for both pharmaceutical manufacturers and healthcare customers.

Rare Diseases Focus There is a advocacy emphasis on making the UK attractive for developing and launching medicines for rare diseases. Targeted opportunities exist in specialized therapies, patient access programs, and NHS negotiation/support services for rare disease portfolios.

Digital & Engagement ABPI maintains a tech stack including platforms like HubSpot, Box, and Azure, indicating potential for enterprise outreach, CRM-driven account-based marketing, and secure digital collaboration tools to streamline partner engagement and stakeholder communications.

Industry Networking Recent partnerships and events with NHS Scotland and AMRC show ABPI’s role in convening industry stakeholders. This creates openings for event sponsorships, thought leadership programs, and collaboration platforms that connect life sciences companies with policymakers and care providers.

Operational Transparency Initiatives like CONNIE for NICE implementation and a focus on accessibility improvements signal a need for systems that support implementation monitoring, change management, and user-friendly health technology assessment workflows for member companies.